16/02/2017 |
Phase I with CIGB-814 in rheumatoid arthritis patients |
CIGB |
Registered |
06/08/2014 |
Heptavalent Conjugate Vaccine against Pneumococcal (VCN7-T) in healthy children. |
CQB |
Registered |
23/04/2014 |
CIGB-500 in acute myocardial infarction (AMIGOS study) |
CIGB |
Registered |
27/06/2014 |
D-002 and glucosamine/chondroitin sulphate in osteoarthritis |
CPN |
Registered |
11/09/2014 |
NeuroEPO-Stroke. Phase I-II |
CIMAB |
Registered |
02/11/2014 |
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II |
CIMAB |
Registered |
22/05/2015 |
Itolizumab for Relapsing Remitting Multiple Sclerosis |
CIM |
Registered |
29/01/2016 |
Predictor of response with CIMAvax EGF© in NSCLC Phase III |
CIM |
Registered |
17/02/2017 |
Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |
06/11/2014 |
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . |
FINLAY |
Registered |
10/11/2014 |
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
CIGB |
Registered |
08/10/2015 |
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
CIM |
Registered |
23/12/2016 |
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus |
CIM |
Registered |
08/04/2015 |
Combifer vs Trofin phase II in anemic pregnant women. |
BIOCEN |
Registered |
12/05/2015 |
Vitamin E/ Platinum salts |
CIDEM |
Registered |
13/04/2015 |
Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II |
BIOCEN |
Registered |
13/04/2015 |
Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. |
BIOCEN |
Registered |
08/04/2015 |
THERESA-5 Study |
CIGB |
Registered |
22/05/2015 |
Safety and pharmacokinetics of CIGB-552 |
CIGB |
Registered |
04/10/2023 |
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana |
FINLAY |
Registered |